Copyright Reports & Markets. All rights reserved.

Global Human Chorionic Gonadotropin Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Global Human Chorionic Gonadotropin Market Research Report 2018

      1 Human Chorionic Gonadotropin Market Overview

      • 1.1 Product Overview and Scope of Human Chorionic Gonadotropin
      • 1.2 Human Chorionic Gonadotropin Segment by Type (Product Category)
        • 1.2.1 Global Human Chorionic Gonadotropin Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
        • 1.2.2 Global Human Chorionic Gonadotropin Production Market Share by Type (Product Category) in 2017
        • 1.2.3 Natural Source Extraction
        • 1.2.3 Recombinant Technology
      • 1.3 Global Human Chorionic Gonadotropin Segment by Application
        • 1.3.1 Human Chorionic Gonadotropin Consumption (Sales) Comparison by Application (2013-2025)
        • 1.3.2 Fertility Clinics
        • 1.3.3 Research Institutions
        • 1.3.4 Others
      • 1.4 Global Human Chorionic Gonadotropin Market by Region (2013-2025)
        • 1.4.1 Global Human Chorionic Gonadotropin Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
        • 1.4.2 North America Status and Prospect (2013-2025)
        • 1.4.3 Europe Status and Prospect (2013-2025)
        • 1.4.4 China Status and Prospect (2013-2025)
        • 1.4.5 Japan Status and Prospect (2013-2025)
        • 1.4.6 Southeast Asia Status and Prospect (2013-2025)
        • 1.4.7 India Status and Prospect (2013-2025)
      • 1.5 Global Market Size (Value) of Human Chorionic Gonadotropin (2013-2025)
        • 1.5.1 Global Human Chorionic Gonadotropin Revenue Status and Outlook (2013-2025)
        • 1.5.2 Global Human Chorionic Gonadotropin Capacity, Production Status and Outlook (2013-2025)

      2 Global Human Chorionic Gonadotropin Market Competition by Manufacturers

      • 2.1 Global Human Chorionic Gonadotropin Capacity, Production and Share by Manufacturers (2013-2018)
        • 2.1.1 Global Human Chorionic Gonadotropin Capacity and Share by Manufacturers (2013-2018)
        • 2.1.2 Global Human Chorionic Gonadotropin Production and Share by Manufacturers (2013-2018)
      • 2.2 Global Human Chorionic Gonadotropin Revenue and Share by Manufacturers (2013-2018)
      • 2.3 Global Human Chorionic Gonadotropin Average Price by Manufacturers (2013-2018)
      • 2.4 Manufacturers Human Chorionic Gonadotropin Manufacturing Base Distribution, Sales Area and Product Type
      • 2.5 Human Chorionic Gonadotropin Market Competitive Situation and Trends
        • 2.5.1 Human Chorionic Gonadotropin Market Concentration Rate
        • 2.5.2 Human Chorionic Gonadotropin Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Human Chorionic Gonadotropin Capacity, Production, Revenue (Value) by Region (2013-2018)

      • 3.1 Global Human Chorionic Gonadotropin Capacity and Market Share by Region (2013-2018)
      • 3.2 Global Human Chorionic Gonadotropin Production and Market Share by Region (2013-2018)
      • 3.3 Global Human Chorionic Gonadotropin Revenue (Value) and Market Share by Region (2013-2018)
      • 3.4 Global Human Chorionic Gonadotropin Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.5 North America Human Chorionic Gonadotropin Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.6 Europe Human Chorionic Gonadotropin Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.7 China Human Chorionic Gonadotropin Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.8 Japan Human Chorionic Gonadotropin Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.9 Southeast Asia Human Chorionic Gonadotropin Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.10 India Human Chorionic Gonadotropin Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

      4 Global Human Chorionic Gonadotropin Supply (Production), Consumption, Export, Import by Region (2013-2018)

      • 4.1 Global Human Chorionic Gonadotropin Consumption by Region (2013-2018)
      • 4.2 North America Human Chorionic Gonadotropin Production, Consumption, Export, Import (2013-2018)
      • 4.3 Europe Human Chorionic Gonadotropin Production, Consumption, Export, Import (2013-2018)
      • 4.4 China Human Chorionic Gonadotropin Production, Consumption, Export, Import (2013-2018)
      • 4.5 Japan Human Chorionic Gonadotropin Production, Consumption, Export, Import (2013-2018)
      • 4.6 Southeast Asia Human Chorionic Gonadotropin Production, Consumption, Export, Import (2013-2018)
      • 4.7 India Human Chorionic Gonadotropin Production, Consumption, Export, Import (2013-2018)

      5 Global Human Chorionic Gonadotropin Production, Revenue (Value), Price Trend by Type

      • 5.1 Global Human Chorionic Gonadotropin Production and Market Share by Type (2013-2018)
      • 5.2 Global Human Chorionic Gonadotropin Revenue and Market Share by Type (2013-2018)
      • 5.3 Global Human Chorionic Gonadotropin Price by Type (2013-2018)
      • 5.4 Global Human Chorionic Gonadotropin Production Growth by Type (2013-2018)

      6 Global Human Chorionic Gonadotropin Market Analysis by Application

      • 6.1 Global Human Chorionic Gonadotropin Consumption and Market Share by Application (2013-2018)
      • 6.2 Global Human Chorionic Gonadotropin Consumption Growth Rate by Application (2013-2018)
      • 6.3 Market Drivers and Opportunities
        • 6.3.1 Potential Applications
        • 6.3.2 Emerging Markets/Countries

      7 Global Human Chorionic Gonadotropin Manufacturers Profiles/Analysis

      • 7.1 Bristol Myers Squibb
        • 7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.1.2 Human Chorionic Gonadotropin Product Category, Application and Specification
          • 7.1.2.1 Product A
          • 7.1.2.2 Product B
        • 7.1.3 Bristol Myers Squibb Human Chorionic Gonadotropin Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.1.4 Main Business/Business Overview
      • 7.2 Merck & Co
        • 7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.2.2 Human Chorionic Gonadotropin Product Category, Application and Specification
          • 7.2.2.1 Product A
          • 7.2.2.2 Product B
        • 7.2.3 Merck & Co Human Chorionic Gonadotropin Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.2.4 Main Business/Business Overview
      • 7.3 Ferring
        • 7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.3.2 Human Chorionic Gonadotropin Product Category, Application and Specification
          • 7.3.2.1 Product A
          • 7.3.2.2 Product B
        • 7.3.3 Ferring Human Chorionic Gonadotropin Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.3.4 Main Business/Business Overview
      • 7.4 Fresenius Kabi
        • 7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.4.2 Human Chorionic Gonadotropin Product Category, Application and Specification
          • 7.4.2.1 Product A
          • 7.4.2.2 Product B
        • 7.4.3 Fresenius Kabi Human Chorionic Gonadotropin Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.4.4 Main Business/Business Overview
      • 7.5 Sun Pharmaceutical
        • 7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.5.2 Human Chorionic Gonadotropin Product Category, Application and Specification
          • 7.5.2.1 Product A
          • 7.5.2.2 Product B
        • 7.5.3 Sun Pharmaceutical Human Chorionic Gonadotropin Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
        • 7.5.4 Main Business/Business Overview

      8 Human Chorionic Gonadotropin Manufacturing Cost Analysis

      • 8.1 Human Chorionic Gonadotropin Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
        • 8.1.4 Market Concentration Rate of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
        • 8.2.1 Raw Materials
        • 8.2.2 Labor Cost
        • 8.2.3 Manufacturing Expenses
      • 8.3 Manufacturing Process Analysis of Human Chorionic Gonadotropin

      9 Industrial Chain, Sourcing Strategy and Downstream Buyers

      • 9.1 Human Chorionic Gonadotropin Industrial Chain Analysis
      • 9.2 Upstream Raw Materials Sourcing
      • 9.3 Raw Materials Sources of Human Chorionic Gonadotropin Major Manufacturers in 2017
      • 9.4 Downstream Buyers

      10 Marketing Strategy Analysis, Distributors/Traders

      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
        • 10.1.3 Marketing Channel Development Trend
      • 10.2 Market Positioning
        • 10.2.1 Pricing Strategy
        • 10.2.2 Brand Strategy
        • 10.2.3 Target Client
      • 10.3 Distributors/Traders List

      11 Market Effect Factors Analysis

      • 11.1 Technology Progress/Risk
        • 11.1.1 Substitutes Threat
        • 11.1.2 Technology Progress in Related Industry
      • 11.2 Consumer Needs/Customer Preference Change
      • 11.3 Economic/Political Environmental Change

      12 Global Human Chorionic Gonadotropin Market Forecast (2018-2025)

      • 12.1 Global Human Chorionic Gonadotropin Capacity, Production, Revenue Forecast (2018-2025)
        • 12.1.1 Global Human Chorionic Gonadotropin Capacity, Production and Growth Rate Forecast (2018-2025)
        • 12.1.2 Global Human Chorionic Gonadotropin Revenue and Growth Rate Forecast (2018-2025)
        • 12.1.3 Global Human Chorionic Gonadotropin Price and Trend Forecast (2018-2025)
      • 12.2 Global Human Chorionic Gonadotropin Production, Consumption , Import and Export Forecast by Region (2018-2025)
        • 12.2.1 North America Human Chorionic Gonadotropin Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.2 Europe Human Chorionic Gonadotropin Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.3 China Human Chorionic Gonadotropin Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.4 Japan Human Chorionic Gonadotropin Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.5 Southeast Asia Human Chorionic Gonadotropin Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.6 India Human Chorionic Gonadotropin Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
      • 12.3 Global Human Chorionic Gonadotropin Production, Revenue and Price Forecast by Type (2018-2025)
      • 12.4 Global Human Chorionic Gonadotropin Consumption Forecast by Application (2018-2025)

      13 Research Findings and Conclusion

        14 Appendix

        • 14.1 Methodology/Research Approach
          • 14.1.1 Research Programs/Design
          • 14.1.2 Market Size Estimation
          • 14.1.3 Market Breakdown and Data Triangulation
        • 14.2 Data Source
          • 14.2.1 Secondary Sources
          • 14.2.2 Primary Sources

        Human chorionic gonadotropin (hCG) belongs to the family of gonadotropin hormones and is naturally produced by the placenta.
        hCG hormone plays a pivotal role after the formation of the embryo, and hence has gained significant traction over the years for the treatment of infertility in women and men. hCG triggers ovulation in women and assists in increasing the sperm count in men.

        This report studies the global Human Chorionic Gonadotropin market status and forecast, categorizes the global Human Chorionic Gonadotropin market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).

        The major manufacturers covered in this report
        Bristol Myers Squibb
        Merck & Co
        Ferring
        Fresenius Kabi
        Sun Pharmaceutical

        Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        We can also provide the customized separate regional or country-level reports, for the following regions:
        North America
        United States
        Canada
        Mexico
        Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Rest of Asia-Pacific
        Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
        Rest of Europe
        Central & South America
        Brazil
        Argentina
        Rest of South America
        Middle East & Africa
        Saudi Arabia
        Turkey
        Rest of Middle East & Africa

        On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
        Natural Source Extraction
        Recombinant Technology
        On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
        Fertility Clinics
        Research Institutions
        Others

        The study objectives of this report are:
        To analyze and study the global Human Chorionic Gonadotropin capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
        Focuses on the key Human Chorionic Gonadotropin manufacturers, to study the capacity, production, value, market share and development plans in future.
        Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
        To define, describe and forecast the market by type, application and region.
        To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
        To identify significant trends and factors driving or inhibiting the market growth.
        To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
        To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
        To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
        To strategically profile the key players and comprehensively analyze their growth strategies.

        In this study, the years considered to estimate the market size of Human Chorionic Gonadotropin are as follows:
        History Year: 2013-2017
        Base Year: 2017
        Estimated Year: 2018
        Forecast Year 2018 to 2025

        For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

        Key Stakeholders
        Human Chorionic Gonadotropin Manufacturers
        Human Chorionic Gonadotropin Distributors/Traders/Wholesalers
        Human Chorionic Gonadotropin Subcomponent Manufacturers
        Industry Association
        Downstream Vendors

        Available Customizations
        With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
        Regional and country-level analysis of the Human Chorionic Gonadotropin market, by end-use.
        Detailed analysis and profiles of additional market players.

        Buy now